Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04102319
Other study ID # hepcidin,Anemia
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 1, 2019
Est. completion date December 1, 2023

Study information

Verified date September 2019
Source Assiut University
Contact Deiaaeldeen Mohamed, master degree
Phone +201032997001
Email deiaa_1981@yahoo.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The current study is planned to assess possible relationships of serum hepcidin levels with haemoglobin levels, inflammation and iron statuses in stage 4 CKD patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 64
Est. completion date December 1, 2023
Est. primary completion date October 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients (>18 years) with anaemia who had CKD stage 4 with glomerular filtration rate (GFR) 15-29 ml/min/1.73 m2

Exclusion Criteria:

- Subjects with blood transfusion within the preceding 3 months. myocardial infarction (MI) history within the preceding 3 months, surgical history within the preceding 3 months, malignancy. Advanced liver cirrhosis. uncontrolled diabetes

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
serum hepcidin
it is a serum marker

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary relation between serum hepcidin level and ESR ckd stage 4 measure strength of relation, r, between levels of serum hepcidin and ESR, an inflammation marker at study entry and then again after 3 months
Primary relation between serum hepcidin and serum ferritin levels measure strength of relation, r, between levels of hecidin and ferritin at study entry and then again after 3 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03596749 - The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4 Phase 3
Not yet recruiting NCT05514184 - Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease N/A
Recruiting NCT03415074 - Could Ketoanalogue-supplemented Low Protein Diet Defer Dialysis in Advanced Diabetic Kidney Disease? (K-DDD) N/A
Recruiting NCT05309785 - Safety and Efficacy of Canagliflozin in Advanced CKD Phase 4
Not yet recruiting NCT06094920 - Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial Phase 4
Completed NCT05705011 - Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.
Completed NCT03588884 - Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency Phase 4
Enrolling by invitation NCT06083545 - The Effects of Application Intervention on the Physiological Indicators and Low Protein Diet Cognition Among the Patients With Chronic Kidney Disease N/A
Recruiting NCT05508009 - Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor Phase 1/Phase 2
Recruiting NCT04633304 - A Single Arm sTudy to Evaluate the Effectiveness of EndoAVF in a Pre-dialysis Population (STEP Study) N/A
Completed NCT04862715 - The Iron and Muscle Study Phase 4